Accessibility Menu
 
Biotron logo

Biotron

(ASX) BIT

Current Price$0.00
Market Cap$8.11M
Since IPO (2001)-99%
5 Year-94%
1 Year+0%
1 Month+50%

Biotron Financials at a Glance

Market Cap

$8.11M

Revenue (TTM)

$1.81M

Net Income (TTM)

$3.35M

EPS (TTM)

$-0.00

P/E Ratio

-1.76

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.00

Volume

1,040,597

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

BIT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biotron

Industry

Biotechnology

CEO

Michelle Miller, PhD

Headquarters

Sydney, NSW 2000, AU

BIT Financials

Key Financial Metrics (TTM)

Gross Margin

2%

Operating Margin

2222%

Net Income Margin

2231%

Return on Equity

-123%

Return on Capital

-71%

Return on Assets

-50%

Earnings Yield

-56.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.11M

Shares Outstanding

2.70B

Volume

1.04M

Avg. Volume

1.75M

Financials (TTM)

Gross Profit

$1.81M

Operating Income

$338.75K

EBITDA

$333.81K

Operating Cash Flow

$565.80K

Capital Expenditure

$3.07K

Free Cash Flow

$568.87K

Cash & ST Invst.

$931.68K

Total Debt

$0.00

Biotron Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$783.00

+96.4%

Gross Margin

0.00%

N/A

Market Cap

$8.11M

N/A

Market Cap/Employee

$2.03M

N/A

Employees

4

N/A

Net Income

$920.97K

+30.4%

EBITDA

$892.16K

+69.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$1.64M

+136.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-50.16%

N/A

Return on Invested Capital

-71.46%

N/A

Free Cash Flow

$868.42K

+73.4%

Operating Cash Flow

$868.42K

+73.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHM.AXChimeric Therapeutics Limited
$0.17-17.50%
IRX.AXInhaleRx Limited
$0.03+0.00%
ZLD.AXZelira Therapeutics Limited
$0.50+0.00%
VBS.AXVectus Biosystems Limited
$0.11-8.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
SOUNSoundHound AI
$9.56+0.20%

Questions About BIT

What is the current price of Biotron?

Biotron is trading at A$0.00 per share.

What is the 52-week range for Biotron?

Over the past 52 weeks, Biotron has traded between A$0.00 and A$0.01.

How much debt does Biotron have?

As of the most recent reporting period, Biotron reported total debt of N/A.

How much cash does Biotron have on hand?

Biotron reported $931,676 in cash and cash equivalents in its most recent financial results.

What is Biotron’s dividend yield?

Biotron does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.